Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Emirates NBD closed NMC LN ABO, GBP12.50 per share

24 Jan 2020 07:00

RNS Number : 8388A
Emirates NBD Capital
24 January 2020
 

 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS, OR IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND NOT AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA.

PRESS RELEASE

 

24 January 2020

Announcement in relation to the results of an accelerated bookbuild

Further to the announcement on 23 January 2020, Emirates NBD Bank (PJSC) ("ENBD") announces the completion of the accelerated bookbuild offering (the "Placing") which has resulted in the sale of 2,163,850 existing ordinary shares (the "Shares") in NMC Health PLC (the "Company") (representing c.1.04% of the issued share capital of the Company) at a price of GBP12.50 per Share, raising gross proceeds of approximately GBP 27,048,125 million.

The sale of the Shares was made pursuant to the repayment of a related loan entered into by Infinite Investment LLC (as borrower) with ENBD (as lender).

The bookrunner for the Placing was Emirates NBD Capital Ltd ("ENBD Capital"). Settlement is expected to occur on 28 January 2020.

Enquiries:

ENBD Capital:

Alan Twinn

Alant@emiratesnbd.com

Tel +971 (0) 4 303 2818

Mob +971 (0) 50 901 1674

 

Prasad Chari

PrasadCH@emiratesNBD.com

Tel +971 (0) 4 303 2897

Mob +971 (0) 50 628 9002

 

IMPORTANT NOTICE

This announcement is for information purposes only and shall not constitute or form part of an offer to buy, sell, issue, acquire or subscribe for, or the solicitation of an offer to buy, sell, issue, acquire or subscribe for any securities (including, without limitation, the Shares), nor shall there be any sale of securities (including, without limitation, the Shares) in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. The offer and sale of the Shares referred to herein has not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") or under the applicable securities laws of Australia, Canada, Japan or South Africa. Absent registration under the Securities Act or an exemption from the registration requirements of the Securities Act, the Shares referred to herein may not be offered or sold in the United States, and subject to certain exceptions, the Shares referred to herein may not be offered or sold in Australia, Canada, Japan or South Africa. There will be no public offer of the Shares in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction.

This announcement is only directed at, and being distributed to persons outside the United States who are: (i) in any member state of the European Economic Area (other than the United Kingdom), qualified investors within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129 of 14 June 2017) ("Qualified Investors"); or (ii) Qualified Investors in the United Kingdom who (A) have professional experience in matters relating to investments (i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order")), are high net worth entities falling within the meaning of Article 49(2)(a) to (d) of the Order or are persons to whom it can otherwise be lawfully distributed (together, such persons referred to in this sub-paragraph (ii) being "relevant persons"). This announcement must not be acted on or relied on (a) in the United Kingdom by persons who are not relevant persons, or (b) in any member state of the European Economic Area (other than the United Kingdom), by persons who are not Qualified Investors. Any investment or investment activity referred to in this announcement is only available to, and will only be engaged in with, (1) relevant persons, in the United Kingdom and (2) Qualified Investors and other persons who are permitted to purchase securities pursuant to an exemption from the Prospectus Regulation and other applicable legislation, in any member state of the European Economic Area (other than the United Kingdom).

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of, and has not been independently verified by, any of ENBD or ENBD Capital or any of their respective affiliates.

ENBD Capital Ltd is regulated by the Dubai Financial Services Authority and ENBD Capital PSC is regulated by the Central Bank of the UAE. ENBD Capital is acting exclusively for ENBD and no other person in connection with the Placing. ENBD Capital and ENBD will not regard any other person as their client in relation to the Placing and will not be responsible to any other person for providing the protections afforded to their clients, nor for providing advice in relation to the contents of this announcement or any transaction, arrangement or other matter referred to herein (including, without limitation, the Placing).

In connection with any offering of the Shares, ENBD Capital and any of its affiliates, acting as an investor for its own account, may take up as a proprietary position any Shares and, in that capacity, may retain, purchase or sell for its own accounts such Shares. In addition, any of such persons may enter into financing arrangements and swaps with investors in connection with which it may from time to time acquire, hold or dispose of Shares. It does not intend to disclose the extent of any such investment or transactions, otherwise than in accordance with any legal or regulatory obligation to do so.

None of ENBD or ENBD Capital, nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or any of their subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURBIMATMTATMMM
Date   Source Headline
19th Mar 20184:01 pmRNSSale of Shares
19th Mar 20183:55 pmRNSExercise of share options
15th Mar 20184:56 pmRNSAmendment: Exercise of Options and Sale of Shares
15th Mar 20184:24 pmRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
7th Mar 20187:00 amRNSFinal Results
28th Feb 201812:36 pmRNSNotice of Results
8th Feb 20189:08 amRNSDirector/PDMR Shareholding
6th Feb 20183:13 pmRNSDirector/PDMR Shareholding
2nd Feb 20187:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20187:00 amRNSCompletion of Fakih IVF acquisition
22nd Jan 20187:00 amRNSEarnings accretive acquisitions in the UAE and KSA
4th Jan 20187:00 amRNSAcquisitions of outstanding minority interests
20th Dec 20177:00 amRNSGroup Strategy & Trading Update
11th Dec 20171:42 pmRNSDirector/PDMR Shareholding
1st Dec 20171:46 pmRNSDirector/PDMR Shareholding
30th Nov 20171:39 pmRNSTotal Voting Rights
28th Nov 20174:25 pmRNSDirector/PDMR Shareholding
24th Nov 20171:26 pmRNSPDMR Notification
17th Nov 20172:09 pmRNSDirector/PDMR Shareholding
17th Nov 20172:00 pmRNSExercise of share options
26th Oct 20171:28 pmRNSShare Plans Block Listing Application
13th Oct 20179:46 amRNSPDMR notification
25th Sep 20178:00 amRNSSignificant Expansion into Kingdom of Saudi Arabia
22nd Sep 20171:47 pmRNSDirector/PDMR Shareholding
19th Sep 20171:24 pmRNSHolding(s) in Company
14th Sep 20179:11 amRNSHolding(s) in Company
8th Sep 20174:22 pmRNSDirector/PDMR Shareholding
7th Sep 20173:40 pmRNSDirector/PDMR Shareholding
23rd Aug 20177:15 amRNSNew O&M Contract
23rd Aug 20177:00 amRNSHalf-year Report
22nd Aug 20172:37 pmRNSHolding(s) in Company
18th Aug 20177:00 amRNSNotice of Results
20th Jul 20172:40 pmRNSPDMR Notification
11th Jul 20172:18 pmRNSHolding(s) in Company
29th Jun 20177:02 amRNSNMC Health Board Changes
29th Jun 20177:00 amRNSTransfer of shareholding between concert parties
12th Jun 201711:00 amRNSDirector/PDMR Shareholding
9th Jun 20172:30 pmRNSDirector/PDMR Shareholding
23rd May 20174:08 pmRNSResults of Voting at AGM
18th May 20174:43 pmRNSDirector/PDMR Shareholding
9th May 20174:39 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSAbu Dhabi regulatory and trading update
24th Apr 20173:38 pmRNSNMC Health AGM and Dividend Timetable
24th Mar 201710:25 amRNSNMC Completion of Acquisition of Al Zahra Hospital
8th Mar 20178:00 amRNSNMC Health promotes Prasanth Manghat to CEO
8th Mar 20177:00 amRNSNMC Final FY 2016 Results
2nd Mar 201711:56 amRNSUPDATE ON PROPOSED ACQUISITION OF AL ZAHRA
1st Mar 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.